News

Sandoz, a Novartis division, announces plans to further strengthen its European antibiotics manufacturing network by further expanding production capabilities in Kundl, Austria and in…
Read More...

CytoDyn Inc. a late-stage biotechnology company developing Vyrologix™ (leronlimab-PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced it…
Read More...

Prestige BioPharma Limited (PBP) and Busan City Government announced that the two organisations have entered into a memorandum of understanding (MOU) for the establishment of Research…
Read More...

BioMed X announced the extension of its ongoing collaboration with Merck. Under the new agreement, Merck will start up to six additional research projects at the BioMed X Institute,…
Read More...

InnoCare a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced that China National Medical Products Administration has approved the Phase I clinical…
Read More...

PerkinElmer, Inc. and Immunodiagnostic Systems Holdings PLC are pleased to announce that they have reached an agreement on the terms of a recommended all cash offer whereby PerkinElmer…
Read More...

Charles River Laboratories International, Inc. announced that it has signed a definitive agreement to acquire Vigene Biosciences, Inc., a premier, U.S.-based gene therapy contract…
Read More...

AffyImmune Therapeutics, Inc., a clinical stage biotechnology company finding safe, effective ways to use CAR T cells against solid cancers, announced that the US Food and Drug…
Read More...

Lennham Pharmaceuticals, a clinical-stage start-up focused on the creative use of deuterium chemistry to improve the metabolic and pharmacological profile of existing compounds,…
Read More...

In Q4 2020 CordenPharma announced both an expansion of non-GMP capacity at our Centre of Excellence for Peptide Process Development in Frankfurt, Germany, and a major increase in…
Read More...

Dr. Reddy's Laboratories Ltd. and Shenzhen Pregene Biopharma Co., Ltd. announced an agreement whereby Dr Reddy's will acquire an exclusive license in the Republic of India for PRG1801,…
Read More...

Eli Lilly and Company and MiNA Therapeutics Limited, a pioneer in RNA activation therapeutics, announced a global research collaboration to develop novel drug candidates using MiNA's…
Read More...

Novasep, a leading supplier of services and technologies for the life sciences industry, is pleased to announce today a further expansion of its Highly Potent Active Pharmaceutical…
Read More...

PerkinElmer, Inc. is pleased to announce it has entered into an agreement to acquire Nexcelom Bioscience for $260 Million in cash. The transaction is expected to close during the second…
Read More...

Emmes (the "Company"), a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation and a…
Read More...

Inscopix Inc. a leading neurotechnology company in California that empowers breakthroughs in brain science announced the signing of a distribution agreement with Animalab, a prominent…
Read More...

Algernon Pharmaceuticals Inc. a clinical stage pharmaceutical development company announces that NP-120 (Ifenprodil) reduced interleukin 6 (IL-6) with statistical significance in its…
Read More...

Hofseth BioCare ASA (HBC), a Norwegian biotech company that develops high-value ingredients and finished products, announced that it has begun a global innovation partnership with…
Read More...

Cerecor Inc. a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare and orphan diseases, announced that the U.S. Food and…
Read More...

Neuroscientists at Northwell Health’s Institute for Neurology and Neurosurgery and The Feinstein Institutes for Medical Research will conduct a multi-centered, randomized, Phase 3…
Read More...